Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery.

  Autonomic nervous system responses during sedative infusions of dexmedetomidine.

  Dual alpha(2)-adrenergic agonist and alpha(1)-adrenergic antagonist actions of dexmedetomidine on human isolated endothelium-denuded gastroepiploic arteries.

  Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit.

  The effects of increasing plasma concentrations of dexmedetomidine in humans.

  The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment.

  Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms.

  The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy.

  Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl.

  Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes.

  The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers.

  Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery.

  Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting.

  The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery.

    Back to Summaries List